Defining Treatment Success in Patients With Immune Thrombocytopenia Receiving Thrombopoietin Receptor Agonist Therapy: Results From a Modified Delphi Consensus Panel. Presented at the European Haematology Association meeting 2018

Research output: Chapter in Book/Report/Conference proceedingConference Contribution (Conference Proceeding)

Original languageEnglish
Title of host publicationHaematologica
Publication statusPublished - 2018

Cite this